BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 15207253)

  • 1. The role of new targeted therapies in small-cell lung cancer.
    Rossi A; Maione P; Colantuoni G; Guerriero C; Gridelli C
    Crit Rev Oncol Hematol; 2004 Jul; 51(1):45-53. PubMed ID: 15207253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of targeted therapy in non-small cell lung cancer.
    Maione P; Rossi A; Airoma G; Ferrara C; Castaldo V; Gridelli C
    Crit Rev Oncol Hematol; 2004 Jul; 51(1):29-44. PubMed ID: 15207252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New targeted therapies and small-cell lung cancer.
    Rossi A; Maione P; Palazzolo G; Sacco PC; Ferrara ML; Falanga M; Gridelli C
    Clin Lung Cancer; 2008 Sep; 9(5):271-9. PubMed ID: 18824449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of small cell lung cancer in the elderly.
    Rossi A; Maione P; Colantuoni G; Guerriero C; Ferrara C; Del Gaizo F; Nicolella D; Gridelli C
    Oncologist; 2005; 10(6):399-411. PubMed ID: 15967834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug therapy for small-cell lung cancer (SCLC)--new molecular strategies for therapy].
    Brückl WM; Lampert S; Zirlik S; Hahn EG; Wiest GH
    Pneumologie; 2008 Jan; 62(1):23-30. PubMed ID: 17948174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topotecan in small cell lung cancer.
    Schiller JH
    Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-27-S20-33. PubMed ID: 9425958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternatives to chemotherapy and radiotherapy in the treatment of small cell lung cancer.
    Shepherd FA
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):30-7. PubMed ID: 11479895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.
    Jänne PA; Freidlin B; Saxman S; Johnson DH; Livingston RB; Shepherd FA; Johnson BE
    Cancer; 2002 Oct; 95(7):1528-38. PubMed ID: 12237922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in management of small-cell lung cancer.
    Chua YJ; Steer C; Yip D
    Cancer Treat Rev; 2004 Oct; 30(6):521-43. PubMed ID: 15325033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of novel treatment strategies.
    Giaccone G
    Oncogene; 2002 Oct; 21(45):6970-81. PubMed ID: 12362278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial.
    Sorensen M; Lassen U; Palshof T; Jensen BB; Johansen J; Jensen PB; Langer SW
    Lung Cancer; 2008 May; 60(2):252-8. PubMed ID: 18036701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing outcomes of cancer care: lessons to be learned from a retrospective review of the management of small cell lung cancer at the Cancer Therapy Centre, Liverpool Hospital, January 1996-July 2000.
    Ellis PM; Delaney G; Della-Fiorentina S; Moylan E
    Australas Radiol; 2004 Sep; 48(3):364-70. PubMed ID: 15344988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.
    Gridelli C; Rossi A; Maione P; Ferrara ML; Castaldo V; Sacco PC
    Oncologist; 2009 Sep; 14(9):909-20. PubMed ID: 19726457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for small cell lung cancer--present status and future prospects.
    Saijo N; Shinkai T; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Nakagawa K; Fukuda M; Minato K; Ohe Y
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):977-83. PubMed ID: 2839118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New advances in the second-line treatment of small cell lung cancer.
    Hurwitz JL; McCoy F; Scullin P; Fennell DA
    Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far?
    Fischer B; Marinov M; Arcaro A
    Cancer Treat Rev; 2007 Jun; 33(4):391-406. PubMed ID: 17368733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small cell lung cancer: patients surviving longer than thirty months. Groupe d'oncologie de langue française.
    Moro D; Jacoulet P; Quoix E; Ranfaing E; Brambilla E; Capron F; Lagrange JL; Milleron B; Lebeau B; Ruffie P
    Anticancer Res; 1994; 14(1B):301-4. PubMed ID: 8166471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates in small cell lung cancer treatment.
    Walker S
    Clin J Oncol Nurs; 2003; 7(5):563-8. PubMed ID: 14603554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for relapsed small-cell lung cancer.
    Azim HA; Ganti AK
    Anticancer Drugs; 2007 Mar; 18(3):255-61. PubMed ID: 17264756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
    Yue X; Zang QC
    Ai Zheng; 2004 Dec; 23(12):1671-6. PubMed ID: 15601558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.